LENSAR, INC. Total Contract Liability
LENSAR, INC. (LNSR) had Total Contract Liability of $3.98 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-03-31
- 2025-12-31: Contract with Customer, Liability $3.98M.
- 2024-12-31: Contract with Customer, Liability $2.37M.
- 2024-03-31: Contract with Customer, Liability $2.12M.
- 2023-12-31: Contract with Customer, Liability $1.92M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2025-12-31 | $3.98M 10-K · filed 2026-03-31 |
| 2024-12-31 | $2.37M 10-K · filed 2026-03-31 |
| 2024-03-31 | $2.12M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.92M 10-K · filed 2026-03-31 |
| 2023-09-30 | $1.62M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.63M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.39M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $935.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $830.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $974.00K 10-Q · filed 2023-08-09 |
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $970.00K 10-K · filed 2024-03-04 |
| 2021-09-30 | $1.01M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $1.14M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $1.06M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $1.05M 10-K · filed 2023-03-16 |
| 2020-09-30 | $883.00K 10-Q · filed 2021-11-08 |
| 2020-06-30 | $922.00K 10-Q · filed 2021-08-06 |
| 2020-03-31 | $916.00K 10-Q · filed 2021-05-06 |
| 2019-12-31 | $895.00K 10-K · filed 2022-03-03 |
| 2019-09-30 | $926.00K 10-Q · filed 2020-11-12 |
| 2018-12-31 | $994.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |